At the completion of this educational session, learners will:
- Know the importance of HCV and HBV screening.
- Understand recently revised screening guidelines for HCV including the addition of birth cohort screening of persons born between 1945 and 1965.
- Appreciate the importance of integrating risk-based screening into the birth cohort from 1945 to 1965, to identify patients who may be infected with HCV.
- Understand data on epidemics of acute HCV infection in high-risk groups and screening/evaluation recommendations.
Ponni V. Perumalswami is an Assistant Professor of Medicine in the Division of Liver Diseases at the Mount Sinai School of Medicine. Her areas of clinical interest include viral hepatitis, cirrhosis, acute/chronic liver diseases and liver transplantation. Her research program focuses on community outreach for hepatitis B and C screening and linking patients to care. She is an investigator for many ongoing clinical trials evaluating the safety and efficacy of new antiviral treatments for chronic hepatitis B and C. She is also funded by NYS Health Foundation to create a HCV telehealth program for primary care providers and specialists in New York State. Dr. Perumalswami is an UNOS-certified Liver Transplant physician and is board certified in lnternal Medicine, Gastroenterology and Transplant Hepatology.
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.